Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al (Q42451161)
Jump to navigation
Jump to search
scientific article published on 16 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al |
scientific article published on 16 December 2013 |
Statements
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone (English)
Z Bago-Horvath
M Filipits
R Greil
H Stoeger
M Rudas
B Mlineritsch
W Kwasny
M Knauer
C Singer
R Jakesz
P Dubsky
R Bartsch
G Steger
M Balic
S Ressler
J W Cowens
J Storhoff
S Ferree
C Schaper
S Liu
C Fesl
T O Nielsen
Austrian Breast and Colorectal Cancer Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference